About The Position
Join GSK's Chief Patient Organisation (CPO) and be part of a global organization that drives innovation, scientific excellence, and patient-centered solutions. At GSK, we are committed to improving lives by ensuring the safe and effective use of our medicines and vaccines, bridging critical scientific insights with impactful healthcare strategies. In this role you will lead a team that applies innovative modelling/ evidence generation approaches to shape reimbursement and access strategy across therapeutic areas. You will partner with cross-functional teams, vendors, and external experts to develop transparent, robust cost-effectiveness, public health impact, budget-impact models as well as models for early decision-making. We value clear scientific thinking, strong communication, and practical problem solving. This role offers career growth, meaningful impact on patient access, and alignment with GSK’s mission of uniting science, technology and talent to get ahead of disease together. This role is hybrid. Expect regular time in the office (typically 2–3 days per week) with flexibility for remote work when appropriate.
Requirements
- Advanced degree in a relevant health discipline, such as, but not limited to, Pharmacy, Medicines, health outcomes research, health economics, economics.
- Significant experience leading development of economic models and outcomes/ health economics research in industry, research organisations or academia
- Proven experience contributing to HTA submissions or reimbursement dossiers.
- Evidence of leading partnerships with Commercial, Market Access and R&D functions.
- Technical skills with modelling software and programming (for example R, Excel, decision-analytic modelling tools).
- Experience managing vendor relationships and assuring quality of outsourced deliverables.
- Excellent written and verbal communication skills to explain models and results to technical and non-technical audiences, and to influence internal / external stakeholders.
- Demonstrated success leading cross-functional teams and aligning stakeholders to deliver complex projects on time.
Nice To Haves
- PhD in a relevant quantitative/ health discipline.
- Track record of peer-reviewed publications as lead or first author on cost-effectiveness or methods research.
- Considerable experience with cost-effectiveness modelling, budget-impact modelling and local adaptations across major markets in Specialty and Oncology Therapy Areas.
- Familiarity with real-world evidence (RWE) sources and their use in model inputs.
- Prior experience in a global pharmaceutical or Biotech/ CRO company, with exposure to multiple HTA systems.
Responsibilities
- Lead, build and mentor an Economic modelling Team across Therapy Areas within Pharma.
- Lead development of global models for medicines preparing for launch/HTA reimbursement applications, in alignment with Medicine Strategy.
- Drive innovation through engagement with external experts/ decision-makers, HTA agencies, methodology and policy forums.
- Facilitate alignment and partnership to enable more effective interactions within the complex stakeholder matrix, e.g. clinical, commercial, market access, medical affairs priority market LOCs.
- Deliver materials to inform internal governance decision making (e.g. Medical Review Board, etc) as relevant.
- Lead early economic models to inform clinical development, trial design and evidence plans.
- Act as an in-house expert for product teams on modelling, Health Technology Assessment (HTA) requirements and payer evidence needs.
- Represent the modelling function in scientific advice meetings, cross-functional asset teams and external engagements.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
What This Job Offers
Job Type
Full-time
Career Level
Director
Number of Employees
5,001-10,000 employees
